DK2367549T3 - Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr - Google Patents

Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr

Info

Publication number
DK2367549T3
DK2367549T3 DK09796916.6T DK09796916T DK2367549T3 DK 2367549 T3 DK2367549 T3 DK 2367549T3 DK 09796916 T DK09796916 T DK 09796916T DK 2367549 T3 DK2367549 T3 DK 2367549T3
Authority
DK
Denmark
Prior art keywords
alfalipoic
pets
osteoarthritis
prevention
acid
Prior art date
Application number
DK09796916.6T
Other languages
English (en)
Inventor
Nolan Zebulon Frantz
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Application granted granted Critical
Publication of DK2367549T3 publication Critical patent/DK2367549T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Feed For Specific Animals (AREA)
DK09796916.6T 2008-12-30 2009-12-29 Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr DK2367549T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14132008P 2008-12-30 2008-12-30
PCT/US2009/069684 WO2010078322A1 (en) 2008-12-30 2009-12-29 Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals

Publications (1)

Publication Number Publication Date
DK2367549T3 true DK2367549T3 (da) 2013-11-04

Family

ID=41723035

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09796916.6T DK2367549T3 (da) 2008-12-30 2009-12-29 Anvendelse af alfalipoinsyre til behandling eller forebyggelse af nedbrydende ledsygdomme, osteoarthritis, bruskskade, og relaterede lidelser hos kæledyr

Country Status (11)

Country Link
US (2) US8952052B2 (da)
EP (2) EP2367549B1 (da)
JP (2) JP5902480B2 (da)
CN (2) CN102271676B (da)
AU (1) AU2009335094B2 (da)
BR (1) BRPI0923854A2 (da)
CA (1) CA2750140C (da)
DK (1) DK2367549T3 (da)
ES (1) ES2432151T3 (da)
RU (1) RU2480023C2 (da)
WO (1) WO2010078322A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2525579C2 (ru) * 2010-05-12 2014-08-20 Хилл`С Пет Ньютришн, Инк. Способы контроля и профилактики воспаления и ослабления воспалительных состояний у животных компаньонов
WO2012087512A1 (en) * 2010-12-23 2012-06-28 Hill's Pet Nutrition, Inc. Pet food compositions and methods for treating arthritis and inflammation associated with arthritis
JP6215954B2 (ja) * 2012-12-14 2017-10-18 ヒルズ・ペット・ニュートリシャン・インコーポレーテッド コンパニオンアニマルのための老化防止の食品
WO2017204297A1 (ja) * 2016-05-26 2017-11-30 椿産業株式会社 飼料要求率改善剤、残存率改善剤、産卵鶏の産卵数改善剤及びこれらの剤の動物に対する給与方法並びに飼料
MX2018016046A (es) 2016-06-27 2019-05-02 Achillion Pharmaceuticals Inc Quinazolina y compuestos indol para tratar trastornos medicos.
ES2953519T3 (es) * 2016-12-15 2023-11-14 Nestle Sa Composiciones y métodos que modulan la vitamina D y el contenido mineral óseo en un animal de compañía
AU2022376760A1 (en) 2021-10-27 2024-05-02 Hansoh Bio Llc Piperidinyl indole derivatives, preparation methods and medicinal uses thereof
JP2025530222A (ja) 2022-09-10 2025-09-11 江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 ２－置換ピペリジン誘導体、その製造方法及び医薬的用途

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3997675A (en) 1974-03-05 1976-12-14 Robert James Eichelburg Cat food coated with ascomycetus or asporogenous yeasts
CA2046170A1 (en) 1990-07-10 1992-01-11 Morton Lawrence Barr Basic aluminum antiperspirant active materials having enhanced activity, antiperspirant active compositions containing such materials, and methods for preparation of such materials and compositions
US5419283A (en) 1992-04-08 1995-05-30 Ciuffo Gatto S.R.L. Animal chew toy of starch material and degradable ethylene copolymer
US5569670A (en) 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5292538A (en) 1992-07-22 1994-03-08 Metagenics, Inc. Improved sustained energy and anabolic composition and method of making
US5339771A (en) 1993-09-15 1994-08-23 Axelrod Herbert R Animal chew toy containing animal meal
DE4427079C2 (de) 1994-07-30 2002-12-19 Viatris Gmbh Verfahren zur Racemisierung von Enantiomeren der alpha-Liponsäure
US5798388A (en) 1996-09-06 1998-08-25 Cellular Sciences, Inc. Method and composition for treating mammalian diseases caused by inflammatory response
US5916912A (en) 1997-06-16 1999-06-29 The Regents Of The University Of California Dietary composition for enhancing metabolism and alleviating oxidative stress
DE19818563C2 (de) 1998-04-25 2003-04-17 Sueddeutsche Kalkstickstoff Verwendung von alpha-Liponsäure zur Verringerung des Appetits und/oder zur Körpergewichtsreduzierung
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6228418B1 (en) 1999-04-07 2001-05-08 Cyvex Nutrition Vegetarian pet treat
US20040228887A1 (en) 1999-05-11 2004-11-18 Champ Charles W. Host-guest processes and formulations for delivering bio-affecting compounds
US6379727B1 (en) 1999-12-29 2002-04-30 John F. Addy Flavoring system for pet foods
DE60018545T2 (de) * 2000-01-20 2006-04-06 Innovet Italia S.R.L. Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
EP1250052A1 (en) 2000-01-25 2002-10-23 Juvenon, Inc. Nutritional supplements for aged pets
MXPA02007466A (es) 2000-02-01 2004-02-26 Muscletech Res And Dev Inc Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza.
US20020025310A1 (en) 2000-02-02 2002-02-28 Bland Jeffrey S. Compositions and methods for promoting healthy joints
US20020115710A1 (en) * 2000-10-31 2002-08-22 Zicker Steven Curtis Composition and method
US20020076469A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
US20090156658A1 (en) 2000-10-31 2009-06-18 Hill's Pet Nutrition, Inc. Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals
US8592479B2 (en) 2000-10-31 2013-11-26 Hill's Pet Nutrition, Inc. Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
EP1247456A3 (en) 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
CA2440480A1 (en) 2001-03-15 2002-09-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
US20030190343A1 (en) 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US6733793B2 (en) 2002-06-04 2004-05-11 Metaproteomics, Llc Oral composition with insulin-like activities and methods of use
FI20022175A0 (fi) 2002-12-10 2002-12-10 Labmax Oy Elintarvikeöljyvalmiste ja sen käyttö
AU2004227998A1 (en) 2003-04-02 2004-10-21 Pharmachem Laboratories, Inc. Novel probiotic compositions and methods of using the same
US20040198998A1 (en) 2003-04-04 2004-10-07 Marian Holerca Glycine-free antiperspirant salts with betaine for enhanced cosmetic products
GB0308952D0 (en) * 2003-04-17 2003-05-28 St Georges Entpr Ltd Method
US20060240037A1 (en) * 2003-06-04 2006-10-26 Edward Fey Methods and compositions for the treatment and prevention of degenerative joint disorders
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US8633247B2 (en) 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US20050085454A1 (en) 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
US20050113287A1 (en) * 2003-10-21 2005-05-26 Motion Potion, Inc. Composition to enhance joint function and repair
KR100573246B1 (ko) * 2003-11-26 2006-04-24 김기수 알파-리포익산 또는 디하이드로리포익산을 함유한골다공증의 예방 및 치료용 조성물
US7078064B2 (en) 2003-12-03 2006-07-18 George Zabrecky Compositions and methods useful for treating and preventing chronic liver disease, chronic HCV infection and non-alcoholic steatohepatitis
US8193240B2 (en) 2004-03-17 2012-06-05 Nestec S.A. Compositions and methods for reducing or preventing obesity
JP2006045100A (ja) * 2004-08-03 2006-02-16 Nisshin Pharma Inc α−リポ酸含有カプセル剤
DE102004050353A1 (de) 2004-10-15 2006-04-20 Basf Ag Verwendung stabiler Ammoniumsalze der Liponsäure zur Behandlung diabetischer und weiterer Störungen
WO2006053010A2 (en) * 2004-11-09 2006-05-18 Hill's Pet Nutrition, Inc. Use of antioxidants for gene modulation
ES2550952T3 (es) 2004-11-24 2015-11-13 Hill's Pet Nutrition, Inc. Composición para su uso en la mejora del aclaramiento hepático de sustancias xenobióticas en un animal
CN101106984B (zh) 2004-11-24 2012-10-24 希尔氏宠物营养品公司 包含硫辛酸的组合物及其用途
US8168161B2 (en) * 2004-12-22 2012-05-01 Hill's Pet Nutrition, Inc. Method to promote oral health in companion animals
AU2005322887B2 (en) * 2004-12-30 2010-03-11 Hill's Pet Nutrition, Inc. Methods for enhancing the quality of life of a senior animal
JP2006219467A (ja) 2005-02-10 2006-08-24 Oriza Yuka Kk 脂肪蓄積阻害剤
US7348034B2 (en) * 2005-03-07 2008-03-25 Access Business Group International Llc Plant based formulations for improving skin moisture, texture, and appearance
US20060228448A1 (en) * 2005-04-11 2006-10-12 The Iams Company Pet food compositions comprising two components
BRPI0609388A2 (pt) 2005-05-11 2011-10-18 Hills Pet Nutrition Inc composição, métodos para realçar a palatabilidade de uma composição para o consumo por um animal, para aumentar a freqüência de ingestão ou a taxa de ingestão de uma composição e para fabricar uma composição, produto, kit, e, meio para comunicar informação sobre ou instruções para misturar e administrar uma composição
US20060270625A1 (en) 2005-05-13 2006-11-30 Eastern Virginia Medical School Nutraceuticals for the treatment of neuropathy
BRPI0613000A2 (pt) 2005-07-14 2012-12-04 Hills Pet Nutrition Inc método para aumentar a longevidade de um animal, artigo de fabricação, kit, e, meio de comunicação de informação acerca de ou instruções para a administração a um animal velho de uma composição
RU2377980C2 (ru) 2005-08-17 2010-01-10 Хилл`С Пет Ньютришн, Инк. Способы и композиции для профилактики и лечения заболеваний почек
EP1956923A1 (en) 2005-11-02 2008-08-20 Nestec S.A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
DE102005057178A1 (de) 2005-11-30 2007-07-19 Basf Ag Verwendung von Zinksalzen der Liponsäure zur Behandlung von Fettstoffwechselstörungen
JP4703388B2 (ja) 2005-12-06 2011-06-15 植田製油株式会社 チオクト酸組成物及びその製造方法
WO2007088046A2 (en) * 2006-02-01 2007-08-09 Nestec S.A. Nutritional system and methods for increasing longevity
JP5119509B2 (ja) 2006-05-18 2013-01-16 ビーエイチエヌ株式会社 活動意欲向上剤
JP4556061B2 (ja) * 2006-07-27 2010-10-06 ビーエイチエヌ株式会社 ヒアルロン酸産生増強剤
DE102006050931A1 (de) 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
US20080233244A1 (en) 2007-03-23 2008-09-25 Solae, Llc Animal food compositions and treats
JP5157007B2 (ja) * 2007-05-11 2013-03-06 ビーエイチエヌ株式会社 骨強化剤
US20080299286A1 (en) 2007-06-04 2008-12-04 David B Josephson Palatability enhancing compositions and foods for pets, and methods regarding the same
AU2009270712B2 (en) * 2008-07-18 2013-02-21 Hill's Pet Nutrition, Inc. Method for enhancing the quality of life of a senior animal

Also Published As

Publication number Publication date
US8952052B2 (en) 2015-02-10
US9271957B2 (en) 2016-03-01
BRPI0923854A2 (pt) 2015-07-28
ES2432151T3 (es) 2013-12-02
EP2367549B1 (en) 2013-08-28
JP2012513766A (ja) 2012-06-21
EP2367549A1 (en) 2011-09-28
US20110269827A1 (en) 2011-11-03
US20150126592A1 (en) 2015-05-07
EP2653161B1 (en) 2015-10-07
JP5902480B2 (ja) 2016-04-13
CN102271676B (zh) 2014-07-23
JP2015109850A (ja) 2015-06-18
AU2009335094A1 (en) 2011-06-23
RU2011132091A (ru) 2013-02-10
CA2750140C (en) 2015-10-06
WO2010078322A1 (en) 2010-07-08
CN102271676A (zh) 2011-12-07
CN103830229A (zh) 2014-06-04
EP2653161A1 (en) 2013-10-23
AU2009335094B2 (en) 2012-11-15
CA2750140A1 (en) 2010-07-08
RU2480023C2 (ru) 2013-04-27

Similar Documents

Publication Publication Date Title
HUS2400026I1 (hu) Helyettesített 1,2,3,4,-tetrahidrociklopenta[b]indol-3-il-ecetsav-származékok, amelyek használhatók autoimmun és gyulladásos rendellenességek kezelésében
DK2464362T3 (da) Probiotisk præparat til forebyggelse eller behandling af mavetarmlidelser hos hunde
HRP20160859T1 (hr) Modificirani proteini rsv f i postupci njihove upotrebe
DK2375907T3 (da) Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller
LT2894165T (lt) Būdai ir kompozicijos, skirti su komplementu susijusių sutrikimų gydymui
BRPI1015569A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias.
BRPI0806559A2 (pt) Sistema e método de monitor para semeadeira
HUE038588T2 (hu) IL-22 mikrobiális rendellenességek kezelésében történõ alkalmazásra
FR2914180B1 (fr) Cage expansive pour chirurgie vertebrale.
DK2451796T3 (da) Tofaanaloger til behandling af dermatologiske lidelser eller tilstande
BRPI0911757A2 (pt) composiÇÕes e mÉtodos para tratar distérbios digestivos.
BRPI1012339A2 (pt) "aparelho de decodificador temporário e método."
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
FR2954689B1 (fr) Dispositif et methode pour la chirurgie rachidienne.
DK2796469T3 (da) Hidtil ukendte sammensætninger og fremgangsmåder til behandling af IgE-medierede forstyrrelser
BRPI0813425A2 (pt) Junção de sangria
NL1036306A1 (nl) Lithographic apparatus and in-line cleaning apparatus.
PL3050571T3 (pl) Preparat enzymu trawiennego do leczenia rzucawki
DK2142186T3 (da) Anvendelse af oligomerer af mælkesyre ved behandling af gynækologiske infektioner
EP2213846A4 (en) METHOD FOR REMOVING A SHAFT RING AND CONNECTING A SHOVEL RING
BRPI0816784A2 (pt) Fatores neuro-endócrinos para o tratamento de doenças degenerativas
IL209336B (en) Compositions for treating hyperproliferative diseases and uses thereof
HRP20160569T1 (hr) Boropeptidni inhibitori enteropeptidaze i njihove uporabe u liječenju pretilosti, pretjerane tjelesne težine i/ili bolesti povezane s abnormalnim metabolizmom masti
HRP20130382T1 (hr) Postupci lijeäśenja pomoä†u glikopegiliranog g-csf
DK2448606T3 (da) Biologisk materiale, som er egnet til terapi af osteoarthrosis, ligamentskader og behandling af ledsygdomme.